nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucloxacillin—Reaction gastrointestinal—Methotrexate—muscle cancer	0.0273	0.0273	CcSEcCtD
Flucloxacillin—Appetite absent—Methotrexate—muscle cancer	0.0183	0.0183	CcSEcCtD
Flucloxacillin—Erythema nodosum—Doxorubicin—muscle cancer	0.0182	0.0182	CcSEcCtD
Flucloxacillin—Candida infection—Etoposide—muscle cancer	0.0145	0.0145	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.0137	0.0137	CcSEcCtD
Flucloxacillin—Oral candidiasis—Doxorubicin—muscle cancer	0.0124	0.0124	CcSEcCtD
Flucloxacillin—Neutropenia—Dactinomycin—muscle cancer	0.0123	0.0123	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.0117	0.0117	CcSEcCtD
Flucloxacillin—Neutropenia—Vincristine—muscle cancer	0.011	0.011	CcSEcCtD
Flucloxacillin—Agranulocytosis—Dactinomycin—muscle cancer	0.011	0.011	CcSEcCtD
Flucloxacillin—Hepatitis—Dactinomycin—muscle cancer	0.0106	0.0106	CcSEcCtD
Flucloxacillin—Erythema multiforme—Dactinomycin—muscle cancer	0.00998	0.00998	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00995	0.00995	CcSEcCtD
Flucloxacillin—Bronchospasm—Etoposide—muscle cancer	0.00939	0.00939	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Vincristine—muscle cancer	0.00932	0.00932	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Vincristine—muscle cancer	0.00927	0.00927	CcSEcCtD
Flucloxacillin—Urethral disorder—Vincristine—muscle cancer	0.00925	0.00925	CcSEcCtD
Flucloxacillin—Jaundice cholestatic—Doxorubicin—muscle cancer	0.00898	0.00898	CcSEcCtD
Flucloxacillin—Neutropenia—Etoposide—muscle cancer	0.00893	0.00893	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Dactinomycin—muscle cancer	0.00853	0.00853	CcSEcCtD
Flucloxacillin—Anaemia—Dactinomycin—muscle cancer	0.0085	0.0085	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00844	0.00844	CcSEcCtD
Flucloxacillin—Renal failure—Etoposide—muscle cancer	0.00837	0.00837	CcSEcCtD
Flucloxacillin—Jaundice—Etoposide—muscle cancer	0.0083	0.0083	CcSEcCtD
Flucloxacillin—Malaise—Dactinomycin—muscle cancer	0.00829	0.00829	CcSEcCtD
Flucloxacillin—Leukopenia—Dactinomycin—muscle cancer	0.00823	0.00823	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Etoposide—muscle cancer	0.00805	0.00805	CcSEcCtD
Flucloxacillin—Agranulocytosis—Etoposide—muscle cancer	0.00794	0.00794	CcSEcCtD
Flucloxacillin—Myalgia—Dactinomycin—muscle cancer	0.00783	0.00783	CcSEcCtD
Flucloxacillin—Discomfort—Dactinomycin—muscle cancer	0.00773	0.00773	CcSEcCtD
Flucloxacillin—Anaemia—Vincristine—muscle cancer	0.00759	0.00759	CcSEcCtD
Flucloxacillin—Colitis—Doxorubicin—muscle cancer	0.00758	0.00758	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Etoposide—muscle cancer	0.00755	0.00755	CcSEcCtD
Flucloxacillin—Candida infection—Doxorubicin—muscle cancer	0.00754	0.00754	CcSEcCtD
Flucloxacillin—Urethral disorder—Etoposide—muscle cancer	0.00749	0.00749	CcSEcCtD
Flucloxacillin—Leukopenia—Vincristine—muscle cancer	0.00735	0.00735	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Dactinomycin—muscle cancer	0.00734	0.00734	CcSEcCtD
Flucloxacillin—Erythema multiforme—Etoposide—muscle cancer	0.00723	0.00723	CcSEcCtD
Flucloxacillin—Convulsion—Vincristine—muscle cancer	0.00712	0.00712	CcSEcCtD
Flucloxacillin—Myalgia—Vincristine—muscle cancer	0.00699	0.00699	CcSEcCtD
Flucloxacillin—Immune system disorder—Etoposide—muscle cancer	0.0069	0.0069	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00683	0.00683	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Vincristine—muscle cancer	0.0067	0.0067	CcSEcCtD
Flucloxacillin—Nervous system disorder—Vincristine—muscle cancer	0.00657	0.00657	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Vincristine—muscle cancer	0.00656	0.00656	CcSEcCtD
Flucloxacillin—Decreased appetite—Dactinomycin—muscle cancer	0.00652	0.00652	CcSEcCtD
Flucloxacillin—Dysgeusia—Etoposide—muscle cancer	0.00651	0.00651	CcSEcCtD
Flucloxacillin—Vascular purpura—Doxorubicin—muscle cancer	0.0064	0.0064	CcSEcCtD
Flucloxacillin—Feeling abnormal—Dactinomycin—muscle cancer	0.00618	0.00618	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Etoposide—muscle cancer	0.00617	0.00617	CcSEcCtD
Flucloxacillin—Anaemia—Etoposide—muscle cancer	0.00615	0.00615	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00613	0.00613	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00611	0.00611	CcSEcCtD
Flucloxacillin—Malaise—Etoposide—muscle cancer	0.006	0.006	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.00596	0.00596	CcSEcCtD
Flucloxacillin—Leukopenia—Etoposide—muscle cancer	0.00595	0.00595	CcSEcCtD
Flucloxacillin—Purpura—Doxorubicin—muscle cancer	0.00594	0.00594	CcSEcCtD
Flucloxacillin—Body temperature increased—Dactinomycin—muscle cancer	0.00593	0.00593	CcSEcCtD
Flucloxacillin—Abdominal pain—Dactinomycin—muscle cancer	0.00593	0.00593	CcSEcCtD
Flucloxacillin—Decreased appetite—Vincristine—muscle cancer	0.00583	0.00583	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Vincristine—muscle cancer	0.00579	0.00579	CcSEcCtD
Flucloxacillin—Convulsion—Etoposide—muscle cancer	0.00576	0.00576	CcSEcCtD
Flucloxacillin—Constipation—Vincristine—muscle cancer	0.00573	0.00573	CcSEcCtD
Flucloxacillin—Eosinophilia—Methotrexate—muscle cancer	0.00566	0.00566	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00562	0.00562	CcSEcCtD
Flucloxacillin—Discomfort—Etoposide—muscle cancer	0.0056	0.0056	CcSEcCtD
Flucloxacillin—Hypersensitivity—Dactinomycin—muscle cancer	0.00553	0.00553	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Vincristine—muscle cancer	0.00548	0.00548	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Etoposide—muscle cancer	0.00543	0.00543	CcSEcCtD
Flucloxacillin—Neutropenia—Methotrexate—muscle cancer	0.00535	0.00535	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Etoposide—muscle cancer	0.00532	0.00532	CcSEcCtD
Flucloxacillin—Abdominal pain—Vincristine—muscle cancer	0.0053	0.0053	CcSEcCtD
Flucloxacillin—Body temperature increased—Vincristine—muscle cancer	0.0053	0.0053	CcSEcCtD
Flucloxacillin—Skin disorder—Etoposide—muscle cancer	0.00527	0.00527	CcSEcCtD
Flucloxacillin—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.00516	0.00516	CcSEcCtD
Flucloxacillin—Diarrhoea—Dactinomycin—muscle cancer	0.00513	0.00513	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00506	0.00506	CcSEcCtD
Flucloxacillin—Renal failure—Methotrexate—muscle cancer	0.00501	0.00501	CcSEcCtD
Flucloxacillin—Hypersensitivity—Vincristine—muscle cancer	0.00494	0.00494	CcSEcCtD
Flucloxacillin—Eosinophilia—Doxorubicin—muscle cancer	0.0049	0.0049	CcSEcCtD
Flucloxacillin—Haematuria—Methotrexate—muscle cancer	0.00486	0.00486	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Methotrexate—muscle cancer	0.00482	0.00482	CcSEcCtD
Flucloxacillin—Vomiting—Dactinomycin—muscle cancer	0.00477	0.00477	CcSEcCtD
Flucloxacillin—Agranulocytosis—Methotrexate—muscle cancer	0.00476	0.00476	CcSEcCtD
Flucloxacillin—Rash—Dactinomycin—muscle cancer	0.00473	0.00473	CcSEcCtD
Flucloxacillin—Decreased appetite—Etoposide—muscle cancer	0.00472	0.00472	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Etoposide—muscle cancer	0.00469	0.00469	CcSEcCtD
Flucloxacillin—Constipation—Etoposide—muscle cancer	0.00464	0.00464	CcSEcCtD
Flucloxacillin—Neutropenia—Doxorubicin—muscle cancer	0.00463	0.00463	CcSEcCtD
Flucloxacillin—Diarrhoea—Vincristine—muscle cancer	0.00459	0.00459	CcSEcCtD
Flucloxacillin—Hepatitis—Methotrexate—muscle cancer	0.00458	0.00458	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Methotrexate—muscle cancer	0.00452	0.00452	CcSEcCtD
Flucloxacillin—Urethral disorder—Methotrexate—muscle cancer	0.00449	0.00449	CcSEcCtD
Flucloxacillin—Feeling abnormal—Etoposide—muscle cancer	0.00447	0.00447	CcSEcCtD
Flucloxacillin—Nausea—Dactinomycin—muscle cancer	0.00446	0.00446	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Etoposide—muscle cancer	0.00444	0.00444	CcSEcCtD
Flucloxacillin—Dizziness—Vincristine—muscle cancer	0.00443	0.00443	CcSEcCtD
Flucloxacillin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00438	0.00438	CcSEcCtD
Flucloxacillin—Renal failure—Doxorubicin—muscle cancer	0.00434	0.00434	CcSEcCtD
Flucloxacillin—Erythema multiforme—Methotrexate—muscle cancer	0.00433	0.00433	CcSEcCtD
Flucloxacillin—Urticaria—Etoposide—muscle cancer	0.00431	0.00431	CcSEcCtD
Flucloxacillin—Jaundice—Doxorubicin—muscle cancer	0.0043	0.0043	CcSEcCtD
Flucloxacillin—Abdominal pain—Etoposide—muscle cancer	0.00429	0.00429	CcSEcCtD
Flucloxacillin—Body temperature increased—Etoposide—muscle cancer	0.00429	0.00429	CcSEcCtD
Flucloxacillin—Vomiting—Vincristine—muscle cancer	0.00426	0.00426	CcSEcCtD
Flucloxacillin—Rash—Vincristine—muscle cancer	0.00423	0.00423	CcSEcCtD
Flucloxacillin—Dermatitis—Vincristine—muscle cancer	0.00422	0.00422	CcSEcCtD
Flucloxacillin—Haematuria—Doxorubicin—muscle cancer	0.00421	0.00421	CcSEcCtD
Flucloxacillin—Headache—Vincristine—muscle cancer	0.0042	0.0042	CcSEcCtD
Flucloxacillin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.00418	0.00418	CcSEcCtD
Flucloxacillin—Immune system disorder—Methotrexate—muscle cancer	0.00413	0.00413	CcSEcCtD
Flucloxacillin—Agranulocytosis—Doxorubicin—muscle cancer	0.00412	0.00412	CcSEcCtD
Flucloxacillin—Hypersensitivity—Etoposide—muscle cancer	0.004	0.004	CcSEcCtD
Flucloxacillin—Nausea—Vincristine—muscle cancer	0.00398	0.00398	CcSEcCtD
Flucloxacillin—Hepatitis—Doxorubicin—muscle cancer	0.00396	0.00396	CcSEcCtD
Flucloxacillin—Urinary tract disorder—Doxorubicin—muscle cancer	0.00391	0.00391	CcSEcCtD
Flucloxacillin—Dysgeusia—Methotrexate—muscle cancer	0.0039	0.0039	CcSEcCtD
Flucloxacillin—Connective tissue disorder—Doxorubicin—muscle cancer	0.00389	0.00389	CcSEcCtD
Flucloxacillin—Urethral disorder—Doxorubicin—muscle cancer	0.00389	0.00389	CcSEcCtD
Flucloxacillin—Erythema multiforme—Doxorubicin—muscle cancer	0.00375	0.00375	CcSEcCtD
Flucloxacillin—Diarrhoea—Etoposide—muscle cancer	0.00371	0.00371	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Methotrexate—muscle cancer	0.0037	0.0037	CcSEcCtD
Flucloxacillin—Anaemia—Methotrexate—muscle cancer	0.00368	0.00368	CcSEcCtD
Flucloxacillin—Malaise—Methotrexate—muscle cancer	0.00359	0.00359	CcSEcCtD
Flucloxacillin—Dizziness—Etoposide—muscle cancer	0.00359	0.00359	CcSEcCtD
Flucloxacillin—Immune system disorder—Doxorubicin—muscle cancer	0.00358	0.00358	CcSEcCtD
Flucloxacillin—Leukopenia—Methotrexate—muscle cancer	0.00357	0.00357	CcSEcCtD
Flucloxacillin—Convulsion—Methotrexate—muscle cancer	0.00345	0.00345	CcSEcCtD
Flucloxacillin—Vomiting—Etoposide—muscle cancer	0.00345	0.00345	CcSEcCtD
Flucloxacillin—Rash—Etoposide—muscle cancer	0.00342	0.00342	CcSEcCtD
Flucloxacillin—Dermatitis—Etoposide—muscle cancer	0.00342	0.00342	CcSEcCtD
Flucloxacillin—Headache—Etoposide—muscle cancer	0.0034	0.0034	CcSEcCtD
Flucloxacillin—Arthralgia—Methotrexate—muscle cancer	0.00339	0.00339	CcSEcCtD
Flucloxacillin—Myalgia—Methotrexate—muscle cancer	0.00339	0.00339	CcSEcCtD
Flucloxacillin—Dysgeusia—Doxorubicin—muscle cancer	0.00338	0.00338	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00337	0.00337	CcSEcCtD
Flucloxacillin—Discomfort—Methotrexate—muscle cancer	0.00335	0.00335	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Methotrexate—muscle cancer	0.00325	0.00325	CcSEcCtD
Flucloxacillin—Nausea—Etoposide—muscle cancer	0.00322	0.00322	CcSEcCtD
Flucloxacillin—Ill-defined disorder—Doxorubicin—muscle cancer	0.0032	0.0032	CcSEcCtD
Flucloxacillin—Nervous system disorder—Methotrexate—muscle cancer	0.00319	0.00319	CcSEcCtD
Flucloxacillin—Anaemia—Doxorubicin—muscle cancer	0.00319	0.00319	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Methotrexate—muscle cancer	0.00318	0.00318	CcSEcCtD
Flucloxacillin—Skin disorder—Methotrexate—muscle cancer	0.00316	0.00316	CcSEcCtD
Flucloxacillin—Malaise—Doxorubicin—muscle cancer	0.00311	0.00311	CcSEcCtD
Flucloxacillin—Leukopenia—Doxorubicin—muscle cancer	0.00309	0.00309	CcSEcCtD
Flucloxacillin—Convulsion—Doxorubicin—muscle cancer	0.00299	0.00299	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00296	0.00296	CcSEcCtD
Flucloxacillin—Arthralgia—Doxorubicin—muscle cancer	0.00294	0.00294	CcSEcCtD
Flucloxacillin—Myalgia—Doxorubicin—muscle cancer	0.00294	0.00294	CcSEcCtD
Flucloxacillin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00292	0.00292	CcSEcCtD
Flucloxacillin—Discomfort—Doxorubicin—muscle cancer	0.0029	0.0029	CcSEcCtD
Flucloxacillin—Dyspepsia—Methotrexate—muscle cancer	0.00286	0.00286	CcSEcCtD
Flucloxacillin—Decreased appetite—Methotrexate—muscle cancer	0.00283	0.00283	CcSEcCtD
Flucloxacillin—Anaphylactic shock—Doxorubicin—muscle cancer	0.00282	0.00282	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.00281	0.00281	CcSEcCtD
Flucloxacillin—Nervous system disorder—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Flucloxacillin—Thrombocytopenia—Doxorubicin—muscle cancer	0.00276	0.00276	CcSEcCtD
Flucloxacillin—Skin disorder—Doxorubicin—muscle cancer	0.00274	0.00274	CcSEcCtD
Flucloxacillin—Feeling abnormal—Methotrexate—muscle cancer	0.00268	0.00268	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Methotrexate—muscle cancer	0.00266	0.00266	CcSEcCtD
Flucloxacillin—Urticaria—Methotrexate—muscle cancer	0.00258	0.00258	CcSEcCtD
Flucloxacillin—Body temperature increased—Methotrexate—muscle cancer	0.00257	0.00257	CcSEcCtD
Flucloxacillin—Abdominal pain—Methotrexate—muscle cancer	0.00257	0.00257	CcSEcCtD
Flucloxacillin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.00257	0.00257	CcSEcCtD
Flucloxacillin—Dyspepsia—Doxorubicin—muscle cancer	0.00248	0.00248	CcSEcCtD
Flucloxacillin—Decreased appetite—Doxorubicin—muscle cancer	0.00245	0.00245	CcSEcCtD
Flucloxacillin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.00243	0.00243	CcSEcCtD
Flucloxacillin—Constipation—Doxorubicin—muscle cancer	0.00241	0.00241	CcSEcCtD
Flucloxacillin—Hypersensitivity—Methotrexate—muscle cancer	0.0024	0.0024	CcSEcCtD
Flucloxacillin—Feeling abnormal—Doxorubicin—muscle cancer	0.00232	0.00232	CcSEcCtD
Flucloxacillin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.0023	0.0023	CcSEcCtD
Flucloxacillin—Urticaria—Doxorubicin—muscle cancer	0.00224	0.00224	CcSEcCtD
Flucloxacillin—Body temperature increased—Doxorubicin—muscle cancer	0.00223	0.00223	CcSEcCtD
Flucloxacillin—Abdominal pain—Doxorubicin—muscle cancer	0.00223	0.00223	CcSEcCtD
Flucloxacillin—Diarrhoea—Methotrexate—muscle cancer	0.00223	0.00223	CcSEcCtD
Flucloxacillin—Dizziness—Methotrexate—muscle cancer	0.00215	0.00215	CcSEcCtD
Flucloxacillin—Hypersensitivity—Doxorubicin—muscle cancer	0.00207	0.00207	CcSEcCtD
Flucloxacillin—Vomiting—Methotrexate—muscle cancer	0.00207	0.00207	CcSEcCtD
Flucloxacillin—Rash—Methotrexate—muscle cancer	0.00205	0.00205	CcSEcCtD
Flucloxacillin—Dermatitis—Methotrexate—muscle cancer	0.00205	0.00205	CcSEcCtD
Flucloxacillin—Headache—Methotrexate—muscle cancer	0.00204	0.00204	CcSEcCtD
Flucloxacillin—Nausea—Methotrexate—muscle cancer	0.00193	0.00193	CcSEcCtD
Flucloxacillin—Diarrhoea—Doxorubicin—muscle cancer	0.00193	0.00193	CcSEcCtD
Flucloxacillin—Dizziness—Doxorubicin—muscle cancer	0.00186	0.00186	CcSEcCtD
Flucloxacillin—Vomiting—Doxorubicin—muscle cancer	0.00179	0.00179	CcSEcCtD
Flucloxacillin—Rash—Doxorubicin—muscle cancer	0.00178	0.00178	CcSEcCtD
Flucloxacillin—Dermatitis—Doxorubicin—muscle cancer	0.00177	0.00177	CcSEcCtD
Flucloxacillin—Headache—Doxorubicin—muscle cancer	0.00176	0.00176	CcSEcCtD
Flucloxacillin—Nausea—Doxorubicin—muscle cancer	0.00167	0.00167	CcSEcCtD
